1. Kawakami Y, Robbins PF, Wang RF, Rosenberg SA: Identification of melanoma antigens recognized by T lymphocytes and their use in the immunotherapy of cancer; in Devita VT, Hellman S, Rosenberg SA (eds.): Principle and Practice of Oncology, Opdate. Philadelphia, Lippincott-Raven, pp 1–20.
2. Topalian SL, Rivoltini L, Mancini M, Ng J, Hartzman RJ, Rosenberg SA: Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barrtrans- formed B cells. Int J Cancer 1994;58:69–79.
3. Takahashi T, Chapman PB, Yang SY, Hara I, Vijayasaradhi S, Houghton AN: Reactivity of autologous CD4+ T lymphocytes against human melanoma: evidence for a shared melanoma antigen presented by HLA-DR15. J Immunol 1995;154:772–779.
4. Darrow TL, Slingluff CL, Seigler HF: The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic Tlymphocytes: evidence for shared tumor antigens. J Immunol 1989;142:3329–3335.
5. Kawakami Y, Zakut R, Topalian SL, Stotter H, Rosenberg SA: Shared human melanoma antigens. Recognition by tumor infiltrating lymphocytes in HLA- A2.1 transfected melanomas. J Immunol 1992;148:638–643.